Need help now? Free crisis lines and helplines, worldwide — chapter 02 →
0 results for

Living With Chronic Illness & Pain — Self-Management, Education & Integrative Care

Category 6 of 20 in chapter 17, The Research Behind It, of Notbroken's Free Metabolic & Mental Health Help Directory: 14 listings, each carefully picked (listed, not endorsed). All 280 listings in The Research Behind It · Open the full directory of 2299 listings.
14
Listings
6 / 20
Category
17 / 18
Chapter
Latest Edition Always download the most up-to-date version, free, at notbroken.io
Know someone who could benefit? Share this guide with them.
Free to use · No account needed
Navigation
Contents
17
The Research Behind It — Free Papers on Chronic Disease and What the Evidence Shows
THE EVIDENCE
THE EVIDENCE

The Research Behind It — Free Papers on Chronic Disease and What the Evidence Shows

Why would a support group, a walking club, a low-carb book or an online CBT course help — and what drives chronic illness in the first place? This chapter gathers the research behind each part of the directory, and the research on causes: metabolic therapies, the nutrients in food, plastics and pollution, stress and trauma, the microbiome, and damp and mould. That is 280 studies, reviews and clinical guidelines, every one free to read and download in full, permanently and without a login. Most are kept in PubMed Central, the US National Library of Medicine's public archive; the rest are open access at the publisher, or free guidance from the World Health Organization and NICE. Each entry says what was found, why it matters here — which listings it backs up, or what it explains about chronic disease — and how strong the evidence is: strong (systematic reviews and guidelines with consistent findings), moderate (smaller or lower-certainty reviews, single large trials and large cohort studies) or early (pilot, cross-sectional and laboratory studies — promising, not proof). Studies that follow people over time show links, not proof of cause, and the entries say so. Where a study was funded by a company, or its authors run a listed programme, the note says so; where a listed book or service was not itself tested, the entry says it backs the approach rather than the product. Research moves on, so read these as good reasons to try something, not guarantees — and talk to your own clinician before changing a treatment or a medicine. Every paper was checked at least twice: by the researcher who chose it and again, independently, against its abstract and full text (the first 186 a third time); its public record was checked for corrections, retractions and expressions of concern (none is retracted), every number was looked up in the full text, and every link was opened in a browser.

Living With Chronic Illness & Pain — Self-Management, Education & Integrative Care

A Meta-Analysis of Health Status, Health Behaviors, and Health Care Utilization Outcomes of the Chronic Disease Self-Management Program — Brady et al., Prev Chronic Dis 2013

Meta-analysis — 23 studies (25 study arms; randomised trials and longitudinal studies), 8,688 participants. Moderate evidence. Prev Chronic Dis 2013;10:120112. DOI 10.5888/pcd10.120112. Free full text in PubMed Central (PMC3547675) — public domain. Note: Effects were small, much of the data came from before-and-after studies rather than randomised trials, and pain and fatigue improved only slightly.
What It Found
Pooled 23 studies (8,688 people) of the six-week Stanford Chronic Disease Self-Management Program, taught by trained leaders. In English-language small groups, at 4–6 months people had small-to-moderate gains in self-efficacy (effect size 0.35), health distress (−0.28), depression (−0.22), symptom-management skills, exercise and talking with doctors, plus slightly fewer hospital days; mood, distress and self-efficacy gains remained at 9–12 months.
Why It Matters Here
Backs up Living a Healthy Life with Chronic Conditions in chapter 10, the handbook of the group course tested here (the book on its own was not tested); relevant to anyone living with one or more long-term conditions.
Meta-analysis — 23 studies (25 study arms; randomised trials and longitudinal studies), 8,688 participants. Moderate evidence. Prev Chronic Dis 2013;10:120112. DOI 10.5888/pcd10.120112. Free full text in PubMed Central (PMC3547675) — public domain. Note: Effects were small, much of the data came from before-and-after studies rather than randomised trials, and pain and fatigue improved only slightly.

Psychological therapies for the management of chronic pain (excluding headache) in adults — Williams et al., Cochrane Database Syst Rev 2020

Cochrane systematic review and meta-analysis — 75 randomised trials, 9,401 adults. Strong evidence. Cochrane Database Syst Rev 2020;8:CD007407. DOI 10.1002/14651858.CD007407.pub4. Free full text in PubMed Central (PMC7437545). Note: Average benefits of CBT are small, and the trials reported little about possible harms.
What It Found
Pooled 75 randomised trials (9,401 adults) of psychological therapies for chronic non-cancer pain other than headache. Cognitive behavioural therapy (CBT) had small benefits over usual care for pain (SMD −0.22), disability (−0.32) and distress (−0.34) at the end of treatment, largely kept at follow-up, and very small benefits over other active treatments. Evidence for behavioural therapy and ACT was very uncertain.
Why It Matters Here
Backs up the CBT approach taught in the pain workbooks in chapter 10 (such as The Pain Management Workbook; the books themselves were not tested) and the chronic-illness therapists in chapter 05; most relevant to adults with long-lasting pain wondering whether psychological help is worth trying.
Cochrane systematic review and meta-analysis — 75 randomised trials, 9,401 adults. Strong evidence. Cochrane Database Syst Rev 2020;8:CD007407. DOI 10.1002/14651858.CD007407.pub4. Free full text in PubMed Central (PMC7437545). Note: Average benefits of CBT are small, and the trials reported little about possible harms.

Acceptance and commitment therapy for patients with chronic pain: A systematic review and meta-analysis on psychological outcomes and quality of life — Ye et al., PLoS One 2024

Systematic review and meta-analysis — 21 randomised trials, 1,298 participants (ACT vs usual care or waiting list). Moderate evidence. PLoS One 2024;19(6):e0301226. DOI 10.1371/journal.pone.0301226. Free full text in PubMed Central (PMC11178235) — open access, CC BY 4.0. Note: Compared only with usual care or waiting lists, no GRADE rating and follow-up only to three months; the 2020 Cochrane review judged ACT evidence very uncertain.
What It Found
Pooled 21 randomised trials (1,298 people) comparing acceptance and commitment therapy (ACT) for chronic pain with usual care or a waiting list. Straight after treatment ACT improved pain interference (SMD −0.50), day-to-day functioning (−0.74), depression (−0.59), anxiety (−0.47), pain acceptance (0.68) and quality of life (0.43), with a smaller effect on pain intensity (−0.37); effects on most outcomes were still present at three months.
Why It Matters Here
Backs up finding an ACT-trained therapist through the ACBS directory or the chronic-illness therapists in chapter 05; relevant to people who want to live more fully alongside pain that has not gone away.
Systematic review and meta-analysis — 21 randomised trials, 1,298 participants (ACT vs usual care or waiting list). Moderate evidence. PLoS One 2024;19(6):e0301226. DOI 10.1371/journal.pone.0301226. Free full text in PubMed Central (PMC11178235) — open access, CC BY 4.0. Note: Compared only with usual care or waiting lists, no GRADE rating and follow-up only to three months; the 2020 Cochrane review judged ACT evidence very uncertain.

Pain neuroscience education in patients with chronic musculoskeletal pain: an umbrella review — Cuenca-Martínez et al., Front Neurosci 2023

Umbrella review — 16 systematic reviews (11 with meta-analysis) of randomised or controlled clinical trials (quality rated with AMSTAR-2). Moderate evidence. Front Neurosci 2023;17:1272068. DOI 10.3389/fnins.2023.1272068. Free full text in PubMed Central (PMC10704151) — open access, CC BY 4.0. Note: All 16 reviews were rated critically low quality, results and teaching methods varied widely, and the authors say better studies are needed before clinical use.
What It Found
Brought together 16 systematic reviews of pain neuroscience education (PNE) — teaching how pain works, as in Explain Pain — for chronic musculoskeletal pain such as back pain, fibromyalgia and osteoarthritis. Adding PNE to other treatments, mostly exercise, seemed to give bigger improvements than those treatments alone, especially on psychological measures; PNE on its own did not clearly improve pain, disability or psychological measures.
Why It Matters Here
Backs up the pain-science education approach behind Explain Pain, Tame the Beast and Retrain Pain in chapter 10 and apps such as Curable in chapter 13 (none tested themselves); suggests they work best alongside exercise or physiotherapy (chapter 12).
Umbrella review — 16 systematic reviews (11 with meta-analysis) of randomised or controlled clinical trials (quality rated with AMSTAR-2). Moderate evidence. Front Neurosci 2023;17:1272068. DOI 10.3389/fnins.2023.1272068. Free full text in PubMed Central (PMC10704151) — open access, CC BY 4.0. Note: All 16 reviews were rated critically low quality, results and teaching methods varied widely, and the authors say better studies are needed before clinical use.

Effect of Graded Sensorimotor Retraining on Pain Intensity in Patients With Chronic Low Back Pain: A Randomized Clinical Trial — Bagg et al., JAMA 2022

Randomised clinical trial — 276 adults, intervention versus sham-procedure control, 1-year follow-up. Moderate evidence. JAMA 2022;328(5):430–439. DOI 10.1001/jama.2022.9930. Free full text in PubMed Central (PMC9346551). Note: A single trial; the pain benefit was small and faded by one year, and the programme was delivered by trained physiotherapists, not self-guided reading.
What It Found
Trial in 276 adults with chronic low back pain of graded sensorimotor retraining, a 12-session programme that starts with pain education and then retrains body sense and movement step by step, compared with sham treatments. At 18 weeks pain was 1 point lower on a 0–10 scale (−1.0, 95% CI −1.5 to −0.4) and disability was also better; at one year disability was still better but the pain difference was no longer significant.
Why It Matters Here
Backs up the approach of the Explain Pain handbook in chapter 10 (its co-author Lorimer Moseley was a trial author; the book itself was not tested) and the physiotherapists in chapter 12 who combine pain education with graded movement; most relevant to people with long-lasting low back pain.
Randomised clinical trial — 276 adults, intervention versus sham-procedure control, 1-year follow-up. Moderate evidence. JAMA 2022;328(5):430–439. DOI 10.1001/jama.2022.9930. Free full text in PubMed Central (PMC9346551). Note: A single trial; the pain benefit was small and faded by one year, and the programme was delivered by trained physiotherapists, not self-guided reading.

Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial — Ashar et al., JAMA Psychiatry 2022

Randomised clinical trial — 151 adults, three arms (pain reprocessing therapy, open-label placebo, usual care), 1-year follow-up. Moderate evidence. JAMA Psychiatry 2022;79(1):13–23. DOI 10.1001/jamapsychiatry.2021.2669. Free full text in PubMed Central (PMC8482298) — open access, CC BY 4.0. Note: One trial in a well-educated, active group with low-to-moderate pain, with sessions given by the method's developers; it was not tested against other leading treatments.
What It Found
Trial of pain reprocessing therapy (PRT), the method in The Way Out, in 151 adults with chronic back pain. After treatment 66% of the PRT group were pain-free or nearly pain-free, against 20% given an open-label placebo and 10% with usual care (Hedges g −1.14 versus placebo, −1.74 versus usual care); a smaller benefit remained at one year (g −0.70 versus placebo).
Why It Matters Here
Backs up the therapy taught in The Way Out in chapter 10 (the trial tested therapist-delivered sessions, not the book); most relevant to people with chronic back pain where no ongoing injury or disease explains the pain.
Randomised clinical trial — 151 adults, three arms (pain reprocessing therapy, open-label placebo, usual care), 1-year follow-up. Moderate evidence. JAMA Psychiatry 2022;79(1):13–23. DOI 10.1001/jamapsychiatry.2021.2669. Free full text in PubMed Central (PMC8482298) — open access, CC BY 4.0. Note: One trial in a well-educated, active group with low-to-moderate pain, with sessions given by the method's developers; it was not tested against other leading treatments.

WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings — WHO 2023

WHO guideline — GRADE-based evidence reviews of 37 non-surgical interventions. Moderate evidence. Geneva: World Health Organization; 2023. ISBN 978-92-4-008178-9. Free from the World Health Organization — open access, CC BY-NC-SA 3.0 IGO. Note: All recommendations are conditional and most rest on low or very low certainty evidence (very low for education and CBT); it covers adults with chronic primary low back pain only.
What It Found
WHO guideline on chronic primary low back pain in adults that weighed 37 non-surgical treatments. As part of care it conditionally recommends options including structured education and advice, exercise programmes, CBT, operant (behavioural) therapy, multicomponent biopsychosocial care, acupuncture, spinal manipulation, massage and NSAIDs, and advises against routine use of opioids, TENS, traction, back braces and several other medicines.
Why It Matters Here
Backs up the pain education, CBT and self-management resources in chapter 10 and the physiotherapy and exercise services in chapter 12 for long-lasting low back pain; useful for anyone deciding which treatments are worth their time.
WHO guideline — GRADE-based evidence reviews of 37 non-surgical interventions. Moderate evidence. Geneva: World Health Organization; 2023. ISBN 978-92-4-008178-9. Free from the World Health Organization — open access, CC BY-NC-SA 3.0 IGO. Note: All recommendations are conditional and most rest on low or very low certainty evidence (very low for education and CBT); it covers adults with chronic primary low back pain only.

Decision aids for people facing health treatment or screening decisions — Stacey et al., Cochrane Database Syst Rev 2024

Cochrane systematic review and meta-analysis — 209 randomised trials, 107,698 people. Strong evidence. Cochrane Database Syst Rev 2024;1:CD001431. DOI 10.1002/14651858.CD001431.pub6. Free full text in PubMed Central (PMC10823577). Note: It tested structured decision aids against usual care, which ranged from general health information to nothing; effects on adherence, health outcomes and costs are unclear.
What It Found
Cochrane review of 209 randomised trials (107,698 people) of patient decision aids — leaflets, videos or online tools that lay out options, benefits and harms. Compared with usual care, people knew more (11.9 points out of 100), judged risks more accurately (RR 1.94), felt better informed and clearer about what mattered to them, took a less passive role (RR 0.72) and probably more often made choices that matched their values (RR 1.75).
Why It Matters Here
Backs up resources that set out treatment options, benefits and harms to weigh with a clinician, such as Deprescribing.org in chapter 06; the review tested structured decision aids, not this site.
Cochrane systematic review and meta-analysis — 209 randomised trials, 107,698 people. Strong evidence. Cochrane Database Syst Rev 2024;1:CD001431. DOI 10.1002/14651858.CD001431.pub6. Free full text in PubMed Central (PMC10823577). Note: It tested structured decision aids against usual care, which ranged from general health information to nothing; effects on adherence, health outcomes and costs are unclear.

Association of the Functional Medicine Model of Care With Patient-Reported Health-Related Quality-of-Life Outcomes — Beidelschies et al., JAMA Netw Open 2019

Retrospective cohort study — 7,252 patients; 398 propensity-matched pairs (functional medicine centre vs primary care), Cleveland Clinic. Early evidence. JAMA Netw Open 2019;2(10):e1914017. DOI 10.1001/jamanetworkopen.2019.14017. Free full text in PubMed Central (PMC6822085) — open access, CC BY. Note: Retrospective, single-centre and not randomised (the authors call it hypothesis-generating); people choosing functional medicine may be more motivated, and the gap was not significant at 12 months.
What It Found
Compared 1,595 patients at the Cleveland Clinic's functional medicine centre (longer visits, dietitian and health coach) with 5,657 primary-care patients (398 matched pairs). At six months the functional medicine group improved more on a standard physical-health score (1.59 vs 0.33 points), and more reached a meaningful gain (30.9% vs 22.1%); at 12 months the difference from primary care was no longer significant.
Why It Matters Here
Backs up, cautiously, the functional and integrative medicine directories in chapter 01 (such as the Institute for Functional Medicine); it tested one hospital clinic's team model, which many listed practitioners do not offer.
Retrospective cohort study — 7,252 patients; 398 propensity-matched pairs (functional medicine centre vs primary care), Cleveland Clinic. Early evidence. JAMA Netw Open 2019;2(10):e1914017. DOI 10.1001/jamanetworkopen.2019.14017. Free full text in PubMed Central (PMC6822085) — open access, CC BY. Note: Retrospective, single-centre and not randomised (the authors call it hypothesis-generating); people choosing functional medicine may be more motivated, and the gap was not significant at 12 months.

Patient navigators for people with chronic disease: A systematic review — McBrien et al., PLoS One 2018

Systematic review (narrative synthesis, no meta-analysis) — 67 randomised trials (cancer, diabetes, HIV, heart and kidney disease, dementia). Moderate evidence. PLoS One 2018;13(2):e0191980. DOI 10.1371/journal.pone.0191980. Free full text in PubMed Central (PMC5819768) — open access, CC BY 4.0. Note: Two-thirds of trials were in cancer care; navigation mostly improved steps in care such as screening and follow-up, but evidence on health, experience and costs is thin.
What It Found
Reviewed 67 randomised trials of patient navigators — people who guide patients through appointments, tests and services — for chronic diseases. Two-thirds of trials (45 of 67) found a significant improvement in their main outcome, mostly 'processes of care', that is, whether recommended care actually happened; few trials measured patient experience, health outcomes or costs.
Why It Matters Here
Backs up the approach behind the case-management and patient-advocacy services in chapter 16 (such as the Patient Advocate Foundation) that help people find their way through care; the programmes tested were mostly clinic- or hospital-based navigators.
Systematic review (narrative synthesis, no meta-analysis) — 67 randomised trials (cancer, diabetes, HIV, heart and kidney disease, dementia). Moderate evidence. PLoS One 2018;13(2):e0191980. DOI 10.1371/journal.pone.0191980. Free full text in PubMed Central (PMC5819768) — open access, CC BY 4.0. Note: Two-thirds of trials were in cancer care; navigation mostly improved steps in care such as screening and follow-up, but evidence on health, experience and costs is thin.

Efficacy of Diet on Fatigue and Quality of Life in Multiple Sclerosis: A Systematic Review and Network Meta-analysis of Randomized Trials — Snetselaar et al., Neurology 2023

Systematic review and network meta-analysis — 12 randomised trials, 608 people with MS, 7 diets. Moderate evidence. Neurology 2023;100(4):e357–e366. DOI 10.1212/WNL.0000000000201371. Free full text in PubMed Central (PMC12326367). Note: Credibility of every direct comparison was rated very low (few, small trials, mostly at moderate or high risk of bias); the authors say results need confirming in better trials.
What It Found
Network meta-analysis of 12 randomised trials (608 people with multiple sclerosis) comparing seven diets with usual eating. Paleolithic-style (the basis of the Wahls Protocol), low-fat and Mediterranean diets were linked with less fatigue (SMD −1.27, −0.90 and −0.89), and Paleolithic and Mediterranean diets with better physical and mental quality of life.
Why It Matters Here
Backs up, with caution, the diets behind The Wahls Protocol (chapter 10) and its practitioner directory (chapter 01), and Overcoming MS's low-saturated-fat diet (chapter 16); relevant to people with MS interested in diet alongside their medical care.
Systematic review and network meta-analysis — 12 randomised trials, 608 people with MS, 7 diets. Moderate evidence. Neurology 2023;100(4):e357–e366. DOI 10.1212/WNL.0000000000201371. Free full text in PubMed Central (PMC12326367). Note: Credibility of every direct comparison was rated very low (few, small trials, mostly at moderate or high risk of bias); the authors say results need confirming in better trials.

Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate — Vist et al., Cochrane Database Syst Rev 2008

Cochrane methodology review — 85 studies (5 randomised, 80 cohort) comparing 86,640 trial participants with 57,205 non-participants. Moderate evidence. Cochrane Database Syst Rev 2008;(3):MR000009. DOI 10.1002/14651858.MR000009.pub4. Free full text in PubMed Central (PMC8276557). Note: It compared the same treatments inside and outside trials, mostly in non-randomised studies published before 2008; it says nothing about the risks of new experimental treatments.
What It Found
Cochrane review of whether people fare better or worse by joining a randomised trial. Across 85 studies comparing 86,640 trial participants with 57,205 similar patients given the same treatment outside a trial, most comparisons found no difference (85 of 98 yes/no outcomes), with a few favouring each side; the authors conclude that taking part is associated with similar outcomes.
Why It Matters Here
Backs up the trial-finding services in chapter 16 (ClinicalTrials.gov, ResearchMatch, TrialMatch) and the trial registries in chapter 15: people treated within trials did about as well as similar patients treated outside them, so joining should not, by itself, be expected to improve or worsen outcomes.
Cochrane methodology review — 85 studies (5 randomised, 80 cohort) comparing 86,640 trial participants with 57,205 non-participants. Moderate evidence. Cochrane Database Syst Rev 2008;(3):MR000009. DOI 10.1002/14651858.MR000009.pub4. Free full text in PubMed Central (PMC8276557). Note: It compared the same treatments inside and outside trials, mostly in non-randomised studies published before 2008; it says nothing about the risks of new experimental treatments.

Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain (NICE guideline NG193) — NICE 2021

National clinical guideline based on systematic evidence reviews and committee consensus. Moderate evidence. NICE NG193, published 7 April 2021. Free to read on the NICE website. Note: Covers people aged 16 and over in England; benefits of the recommended treatments were often modest, and for pain caused by another condition other NICE guidance applies.
What It Found
England's national guideline for chronic pain. For chronic primary pain (pain with no condition that adequately explains it) it recommends a supervised group exercise programme, staying active, and considering ACT or CBT for pain, a single course of acupuncture in set conditions, or certain antidepressants. It advises against starting opioids, gabapentinoids, benzodiazepines, NSAIDs or paracetamol for this kind of pain, and against TENS, ultrasound or biofeedback.
Why It Matters Here
Backs up the exercise professionals and programmes in chapter 12, the therapists in chapter 05 who offer ACT or CBT for pain, and the CBT and ACT skills in pain workbooks in chapter 10 (NICE recommends therapist-led therapy and made no recommendation on pain education or pain programmes).
National clinical guideline based on systematic evidence reviews and committee consensus. Moderate evidence. NICE NG193, published 7 April 2021. Free to read on the NICE website. Note: Covers people aged 16 and over in England; benefits of the recommended treatments were often modest, and for pain caused by another condition other NICE guidance applies.

Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline NG206) — NICE 2021

National clinical guideline based on systematic evidence reviews and committee consensus. Moderate evidence. NICE NG206, published 29 October 2021. Free to read on the NICE website. Note: Much of the evidence was low or very low quality, and its advice on graded exercise and CBT was contested before publication (NICE held a roundtable on the concerns in October 2021).
What It Found
England's guideline for ME/CFS says there is currently no curative treatment, and recommends energy management (pacing): a self-led plan, supported by a specialist team, that keeps activity within each person's fluctuating energy limits to reduce the risk of post-exertional malaise. It says not to offer graded exercise therapy or any fixed, incremental exercise programme, and to offer CBT only as support for living with the illness, not as a treatment that ends it.
Why It Matters Here
Backs up the approach of the #MEAction pacing guide in chapter 10 and the ME/CFS organisations in chapter 06, and is an important caution for anyone in chapters 12 and 13 offering exercise to people with ME/CFS.
National clinical guideline based on systematic evidence reviews and committee consensus. Moderate evidence. NICE NG206, published 29 October 2021. Free to read on the NICE website. Note: Much of the evidence was low or very low quality, and its advice on graded exercise and CBT was contested before publication (NICE held a roundtable on the concerns in October 2021).
Important Disclaimer
This directory is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making changes to your medication regimen or starting any new therapy.

This document does not guarantee the legitimacy, quality, or suitability of any business, organization, or practitioner listed within. The inclusion of any listing does not constitute an endorsement, recommendation, or verification of credentials. All organizations listed are independent entities over which the creators of this directory have no control or oversight.

This directory is intended to be used as a starting point and reference for the reader to conduct their own research, exercise their own judgment, and apply their own discretion before engaging with any listed organization or professional. Readers are strongly encouraged to independently verify credentials, read reviews, check licensing, and confirm current pricing and availability directly with each organization before committing to any services.

Costs, availability, contact details, and services may change at any time without notice. Information was accurate to the best of our knowledge at the time of publication.

About Notbroken.io: this directory and the accompanying Breathe, Calm, Sleep, Move, Eat, Track and Build tools were created by Nathan Leary, who runs and updates them. How each tool works, its safety notes, the privacy policy and terms of use are at notbroken.io/about, notbroken.io/privacy and notbroken.io/terms. The tools are general wellness aids, not medical devices, and Track is a personal journal that never gives medication advice.

If you are in crisis: Please contact your local emergency services immediately, or reach out to one of the following helplines:

International: Chapter 02 of this directory lists free helplines by situation and country; elsewhere use Find A Helpline — findahelpline.com
United States: 988 Suicide & Crisis Lifeline (call or text 988) • Crisis Text Line (text HOME to 741741)
United Kingdom: Samaritans — 116 123 (free, 24/7)
Canada: Talk Suicide Canada — 988 (call or text, 24/7)
Australia: Lifeline — 13 11 14 (24/7) • Beyond Blue — 1300 22 4636
New Zealand: Need to Talk? — 1737 (free, 24/7)
Europe: European Emergency Number — 112
India: iCall — 9152987821 • Vandrevala Foundation — 1860 2662 345
Singapore: Samaritans of Singapore — 1-767 (24/7)
Japan: TELL Lifeline — 03-5774-0992

No matches found

Nothing matched . Try broadening your search — remove a filter, use a single keyword, describe what you need in a sentence, or browse by a condition, a place, or a type of support.

Suggest a resource